Breast cancer in men. Case report
DOI:
https://doi.org/10.29166/rfcmq.v49i2.6657Keywords:
Male breast neoplasms, male, adenopathies, radical mastectomy, oncologyAbstract
Introduction: Male breast cancer is an infrequent pathology; it represents less than 1% of malignant breast pathology, with an average age of diagnosis of 67 years. It has a worse prognosis than female breast cancer, due to its high genetic origin and low suspicion, which leads to inadequate and late diagnosis, becoming evident in advanced stages, decreasing survival in the medium and long term.
Objective: To describe the clinical case of a patient diagnosed with breast cancer, addressing the clinical presentation, diagnostic methods, oncospecific treatment, as well as the corresponding clinical and surgical evolution.
Case presentation: We present a 52-year-old male patient, with evidence of exophytic lesion in right breast plus ipsilateral axillary node, with diagnosis confirmed by pathology report of breast cancer, clinical stage: cT4bN1Mx. A multidisciplinary management is proposed, initially the patient receives neoadjuvant chemotherapy, then undergoes a surgical procedure: radical right mastectomy. Finally, she receives oncospecific treatment in the specialties of clinical oncology and radiotherapy, with favorable evolution.
Discussion: Male breast cancer has a low incidence compared to women, so its diagnostic suspicion is limited. In initial stages the diagnosis is unspecific due to the few clinical manifestations, but should be supported by imaging methods and confirmatory methods, an anatomopathological and immunohistochemical analysis, to guide oncospecific treatment.
Conclusions: Male breast cancer, is an infrequent pathology with limited diagnostic suspicion, which requires specific multidisciplinary management. It is important to have a continuous medical follow-up of the patient, to achieve at the time of diagnosis a correct clinical and immunohistochemical staging, which allows to focus on the appropriate management and treatment, with better clinical outcomes and better survival rates
Downloads
Metrics
References
1. Nofal M, Yousef A. El diagnóstico de cáncer de mama masculino. Neth J Med [Internet]. 2019[Cited Apr 9, 2024];77(10):356–9. Available from: http://www.njmonline.nl/getpdf.php?id=2169
Chehab JC, Montes HD, Campoverde NP. Cáncer de mama en el hombre. Reporte de caso. Rev la Fac Cienc Méd Univ Cuenca [Internet]. 2022[Cited Apr 9, 2024];40(1):47–52. Available from: DOI: https://doi.org/10.18537/RFCM.40.01.07
Prada N, Ángel J, Ríos D. Cáncer de mama en hombres. ¿Es una entidad diferente al cáncer de mama en la mujer? Revisión de la literatura. Rev Colomb Cancerol [Internet].2014[Cited Apr 9, 2024];18(2):78–82. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0123901514000079
López-López JL, Atri-Salame N, Borges-Ocejo X, Salame-Waxman D. Breast cancer in a young male. Med Interna Mex [Internet].2022[Cited Mar 15, 2024];1;38(5):1080–9. Available from: https://www.medigraphic.com/pdfs/medintmex/mim-2022/mim225l.pdf
Abdelwahab AJ. Male Breast Cancer: Epidemiology and Risk Factors. Semin Oncol [Internet].2017 [Cited Mar 5, 2024];44(4):267–72. Available from: DOI: 10.1053/j.seminoncol.2017.11.002
Camejo N, Castillo C, Shiavone A, Alfonso AL, Amarillo D, Xavier F, et al. Características del cáncer de mama masculino en una población uruguaya. AnFac Med [Internet].2018[Cited Mar 15, 2024];5(1):46–67. Available from: https://doi.org/10.25184/anfamed2018v5n1a7.
García-Redondo M, Pareja-López A, López–Ruiz N, Rodríguez-Alonso JM. Cáncer de mama: nueva clasificación molecular. Rev. senol. patol. mamar [Internet].2023[Cited Mar 15, 2024]; 36(2). Available from: https://pesquisa.bvsalud.org/portal/resource/pt/ibc-223848
Yadav S, Karam D, Bin Riaz I, Xie H, Durani U, Duma N, et al. Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century. Cancer [Internet].2020[Cited Jan 18, 2024];126(1):26–36. Available from: https:// acsjournals.onlinelibrary.wiley.com/doi/ full/10.1002/cncr.32472
Tanca J, Real J, Jaramillo L, Quinto R. Cáncer en Guayaquil. Registro de Tumores SOLCA-Guayaquil. Sociedad de Lucha contra el Cáncer. Informe año 2019 [Internet].2019[Cited Jan 18, 2024]. Available from: http://www.estadisticas. med.ec/Publicaciones/Publicacion_ RT_2015_22-nov-2019_enero-2020.pdf
Pensabene M, Von Arx C, De Laurentiis M. Male Breast Cancer: From Molecular Genetics to Clinical Management. Cancers (Basel) [Internet].2022[Cited Jan18, 2024];15(14):2006. Available from: DOI: 10.3390/cancers14082006
Alipio TI, Cisneros LE, Loyo Cosme JA. Cáncer de mama en hombre. Reporte de caso. Cir Gen [Internet].2021[Cited Mar 18, 2024];43(4):248-250. Available from: https://dx.doi.org/10.35366/109128
Martínez N, Chamorro J, Moreno J, González C. Male breast cancer - An orphan entity. Revis En Cancer [Internet]. 2023 [Cited Febr 8, 2024];36(5):246-252. Available from: https://doi.org/10.20960/revcancer.00022.
European Society for Medical Oncology (ESMO). European Society for Medical Oncology [Internet]. 2023 [Cited Febr 8, 2024].Available from: https://www.esmo.org/living-guidelines/esmo-metastatic-breast-cancer-living-guideline/diagnosis-and-staging
Fentiman IS. Surgical options for male breast cancer. Breast Cancer Res Treat [Internet].2018 [Cited Mar18, 2024]; 172: 539-544. Available from: DOI: 10.1007/s10549-018-4952-2
AlFehaid M. Male Breast Cancer (MBC) - A Review. Pol Przegl Chir [Internet].2023 [Cited Apr 18, 2024];95(6):24-30. Available from: https://pubmed.ncbi.nlm.nih.gov/38058163/
Paz MP, Rojas CV, Miller HG. Características Inmuno Histoquímicas del Cáncer de Mama en varones. Soc Cir Gen del Peru [Internet].2012 [Cited Jan 28, 2024]; 25–31. Available from: https://www.imbiomed.com.mx/articulo.php?id=81960
Wang F, Shu X, Meszoely I, Pal T, Mayer IA, Yu Z, et al. Overall Mortality after Diagnosis of Breast Cancer in Men vs Women. JAMA Oncol [Internet].2019 [Cited Jan 28, 2024]; 5(11):1589–1596. Available from: DOI: 10.1001/jamaoncol.2019.2803
Hurtado V. Tratamiento Neoadyuvante en cáncer de mama HER2 positivo. La era de la terapia dirigida. Rev. Oncol. Ecu [Internet].2020 [Cited Jan 28, 2024]; 30(3):237-248. Available from: https://doi.org/10.33821/4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 MARCO FABRICIO BOMBON
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.